Open access · OA
via Europe PMC
Testing the Translational Potential of Rapamycin on Healthy Aging
Authors not listed
Innovation in aging · 2025
Abstract
This study examines the translational potential of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) in the context of healthy aging. It was published in Innovation in aging in 2025.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-07-01 MST
Cite this
APA
Anonymous. (2025). Testing the Translational Potential of Rapamycin on Healthy Aging. <em>Innovation in aging</em>. https://europepmc.org/article/PMC/PMC12759609
Vancouver
Anonymous. Testing the Translational Potential of Rapamycin on Healthy Aging. Innovation in aging. 2025.
BibTeX
@article{anon2025Testin,
title = {Testing the Translational Potential of Rapamycin on Healthy Aging},
author = {Anonymous},
journal = {Innovation in aging},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Methods 2014
Preprint · OA
Studying aging in Drosophila
Elsevier eBooks 2006
Citation only
Drosophila Models of Aging
Ageing Research Reviews 2018
Preprint · CC-BY
Anti-senescence compounds: A potential nutraceutical approach to healthy aging
Aging 2011
Open access · CC-BY
Progeria, rapamycin and normal aging: recent breakthrough
Experimental Gerontology 2010
Preprint · OA
The Role of Mitochondria in Drosophila Aging
Nature Aging 2021
Open access · OA